The U.S. Food and Drug Administration on Tuesday ordered makers of popular weight-loss and diabetes drugs, including Ozempic and Mounjaro, to add a warning about possible optic neuropathy, which can cause sudden vision loss.
Today's highlights
🌏 Regional Digest
🏷️ Topic Digest
🗞️ Latest news by region
Loading...
